ISO 14971:2019 - Medical Device Risk Management for Software Professional Free Practice Test — 30 Questions

Question 1

Consider a software-based medical device, a diagnostic imaging system, that has been on the market for several years. The manufacturer decides to introduce a significant software update that incorporates a novel artificial intelligence (AI) algorithm designed to automatically detect subtle anomalies in medical scans, a feature not present in the original design. This AI algorithm processes image data in a complex, non-deterministic manner. According to the principles of ISO 14971:2019, what is the most appropriate risk management action to take when integrating this new AI functionality into the existing device?

Accepted Answer

Conduct a comprehensive re-evaluation of the entire risk management file, including a thorough hazard analysis for the new AI algorithm and its interaction with existing software components, followed by an assessment of the residual risk and implementation of necessary risk control measures.

Question 2

A software medical device designed for remote patient monitoring, which utilizes a proprietary communication protocol, has been in clinical use for two years. During this period, a series of user reports indicate that under specific network congestion conditions, the device occasionally fails to transmit critical patient vital signs to the central monitoring station. This failure mode was not anticipated or documented in the initial risk management file developed according to ISO 14971:2019. What is the most appropriate immediate action to ensure ongoing compliance with the risk management standard?

Accepted Answer

Initiate a formal review and update of the risk management file to include the newly identified failure mode, re-evaluate associated risks, and implement necessary risk control measures.

Question 3

A critical software defect is discovered in a deployed Class II medical device\'s diagnostic imaging system during routine post-market surveillance. This defect, which can lead to intermittent misinterpretation of scan data under specific, albeit rare, operational conditions, was not identified during pre-market testing. What is the most comprehensive and compliant action the manufacturer must undertake according to ISO 14971:2019 principles for medical device risk management?

Accepted Answer

Update the risk management file to include the newly identified hazard and associated risks, evaluate the residual risk, and implement any necessary additional risk control measures, including potential software updates.

Question 4

A medical device manufacturer is developing a software update for a widely used patient monitoring system. This update introduces a new feature that aggregates physiological data from multiple sensors and presents it in a consolidated dashboard. During the risk analysis phase, it is identified that a potential hazard exists where the aggregation algorithm might incorrectly prioritize or filter data streams under specific, albeit rare, network latency conditions, potentially leading to delayed or missing critical alerts for patient deterioration. Which of the following best describes the manufacturer\'s primary responsibility concerning this identified hazard according to ISO 14971:2019?

Accepted Answer

Implement robust risk control measures to mitigate the likelihood or severity of the incorrect data aggregation, such as employing redundant data validation checks and defining clear acceptable thresholds for data latency, and then re-evaluate the residual risk to ensure it is acceptable.

Question 5

Consider a software-controlled infusion pump used for critical care. A planned update to the device\'s firmware aims to enhance the user interface for faster selection of pre-programmed drug libraries and to improve the algorithm for calculating drip rates based on new clinical guidelines. This update modifies the software\'s core functionality related to drug administration and dose calculation. According to ISO 14971:2019 principles, what is the most appropriate action regarding the risk management file for this device following the firmware update?

Accepted Answer

Conduct a comprehensive review and update of the entire risk management file, including hazard analysis, risk analysis, and risk evaluation, to assess the impact of the firmware changes on device safety and to verify the effectiveness of any new or modified risk control measures.

Question 6

Following the successful market release of a novel AI-driven diagnostic imaging software, a post-market surveillance report details an incident where a subtle, previously uncharacterized artifact in a specific patient population\'s imaging data led to a statistically significant increase in false-negative diagnostic outcomes. This anomaly was not explicitly identified or addressed during the pre-market risk assessment and mitigation planning. Which of the following actions best reflects the required response according to ISO 14971:2019 for such a critical post-production finding?

Accepted Answer

Conduct a comprehensive review of the entire risk management process, including hazard identification, risk analysis, risk evaluation, and risk control measures, to incorporate the lessons learned from this anomaly.

Question 7

Consider a Class II medical device incorporating complex firmware, which is scheduled for a routine security patch update. The manufacturer has identified that this update will modify the device\'s operating system\'s memory management routines to enhance protection against potential cyber threats. Which of the following actions best reflects the comprehensive risk management approach mandated by ISO 14971:2019 for this scenario, considering potential regulatory implications?

Accepted Answer

Conduct a targeted risk assessment focusing solely on the security vulnerabilities addressed by the patch and verify the patch's successful installation.

Question 8

Consider a scenario where a medical device manufacturer is preparing to release a significant software update for their diagnostic imaging system. This update aims to improve the speed of image reconstruction, a feature directly impacting the user experience and potentially the efficiency of diagnostic workflows. However, the development process has also introduced subtle changes to data handling protocols within the software\'s core processing engine. According to ISO 14971:2019, what is the most critical step to undertake before deploying this software update to ensure continued compliance with risk management principles?

Accepted Answer

Conduct a thorough review and update of the entire risk management file, including hazard analysis, risk evaluation, and risk control measures, to account for the implications of the software update on device safety.

Question 9

A manufacturer is preparing to release a significant software update for their diagnostic imaging system, which includes enhanced image processing algorithms and a new user interface. According to ISO 14971:2019, what is the primary risk management activity that must be undertaken *before* this software update is deployed to clinical sites?

Accepted Answer

Review and update the risk management file to account for the new software version's functionalities and potential hazards.

Question 10

A medical device manufacturer is planning to update the firmware of a complex diagnostic imaging system. This update is intended to improve image processing algorithms and introduce a new user interface element for faster data entry. Considering the principles outlined in ISO 14971:2019 for managing risks associated with medical devices, what is the most critical initial step to take regarding the risk management process before deploying this firmware update?

Accepted Answer

Conduct a comprehensive risk analysis of the proposed firmware modification to identify any new hazards or changes to existing risks.

Question 11

A critical software bug is identified in a deployed medical device during its post-market surveillance phase. This bug, previously undetected, has the potential to cause a significant deviation in a vital patient monitoring parameter, leading to a hazardous situation. According to ISO 14971:2019, what is the immediate and most crucial action required from the manufacturer\'s risk management process?

Accepted Answer

Initiate a comprehensive re-evaluation of the risk management file, focusing on the identified defect, its potential hazards, and the effectiveness of existing risk control measures, followed by the implementation of necessary additional controls.

Question 12

Consider a scenario where a software-controlled infusion pump, intended for precise intravenous delivery of critical medications, experiences a latent defect. This defect, under specific, albeit infrequent, operating conditions, can cause a deviation in the delivered dosage by a factor of $ \pm 15\% $. If this dosage deviation occurs during the administration of a narrow therapeutic index drug, it could lead to severe patient harm, including organ damage or death. The manufacturer has identified this potential failure mode during post-market surveillance. Which of the following actions best represents the most appropriate risk control measure according to the principles outlined in ISO 14971:2019 for addressing this identified hazard?

Accepted Answer

Develop and deploy a software update that corrects the underlying defect, thereby preventing the dosage deviation, and then re-evaluate the residual risk.

Question 13

Consider a scenario where a medical device\'s software, intended for patient monitoring, experiences an unexpected data corruption issue during prolonged operation, leading to a temporary loss of vital sign readings. Post-market surveillance data reveals this issue occurs in approximately 0.5% of devices after 18 months of continuous use. This malfunction was not identified during the initial risk analysis for the software. What is the most appropriate action according to ISO 14971:2019 principles for managing risks associated with this software?

Accepted Answer

Initiate a review of the risk management file, re-evaluate the identified hazards and risks associated with data integrity, implement appropriate risk control measures to mitigate the data corruption, and document these actions.

Question 14

A medical device manufacturer is implementing a significant update to the firmware of a Class II diagnostic software. This update includes a new algorithm for data processing and introduces compatibility with a previously unsupported operating system. According to ISO 14971:2019, what is the mandatory action concerning the device\'s risk management file following this firmware update?

Accepted Answer

A comprehensive re-evaluation of the entire risk management file, including hazard identification, risk analysis, risk evaluation, and risk control measures, to account for the new algorithm and operating system compatibility.

Question 15

Consider a scenario where a sophisticated diagnostic imaging software, operating on a networked medical device, has been in clinical use for two years. Post-market surveillance data reveals a statistically significant increase in instances where the software incorrectly interprets subtle anomalies in patient scans, leading to a higher rate of false-negative diagnoses than initially predicted during development. This emergent pattern was not identified during the extensive pre-market verification and validation activities. According to the principles outlined in ISO 14971:2019, what is the most appropriate immediate action for the manufacturer regarding their risk management process for this software?

Accepted Answer

Initiate a comprehensive review of the risk management file, updating the risk analysis to incorporate the newly identified failure mode, re-evaluating the risk acceptability, and implementing revised or additional risk control measures to mitigate the observed diagnostic inaccuracies.

Question 16

Consider a scenario where a software-driven diagnostic imaging device, after its initial market release, begins to receive reports of intermittent, subtle data corruption in a specific imaging modality. This corruption, while not immediately leading to a misdiagnosis, has been linked by the manufacturer\'s post-market surveillance team to a rare environmental factor not fully characterized during the initial risk assessment. According to the principles of ISO 14971:2019, what is the most appropriate and comprehensive action the manufacturer must undertake to address this emerging risk?

Accepted Answer

Initiate a thorough review of the risk management file, re-evaluate the identified hazards and their associated risks considering the new environmental factor, and implement or refine risk control measures for the software to mitigate the data corruption, documenting all changes.

Question 17

A software-controlled infusion pump, designed for precise intravenous drug delivery, undergoes a post-market software update to enhance its user interface and add a new drug library. During the validation of this update, a previously unidentified failure mode is discovered where a specific sequence of user inputs, combined with a rare network communication error, can lead to an unintended bolus delivery of medication. This failure mode was not present in the original risk assessment conducted during the device\'s initial development and approval. According to ISO 14971:2019, what is the most appropriate action concerning the risk management file for this infusion pump?

Accepted Answer

Update the risk management file to include the newly identified failure mode, its associated hazards, risk analysis, and risk control measures, followed by a re-evaluation of the overall residual risk acceptability.

Question 18

When a medical device software, currently in post-market surveillance, is updated to incorporate a novel machine learning-based diagnostic algorithm designed to improve early detection of a specific condition, what is the most appropriate risk management action according to ISO 14971:2019 principles?

Accepted Answer

Conduct a full re-evaluation of the entire risk management file for the device, including hazard identification, risk analysis, and risk evaluation for the modified software.

Question 19

Following the implementation of a software-based risk control measure designed to prevent erroneous data transmission in a diagnostic imaging system, the verification activities reveal that the control measure, while technically functional, fails to reduce the probability of the hazardous event to the acceptable risk level defined in the risk management plan. What is the most appropriate subsequent action according to the principles of ISO 14971:2019 for medical device software risk management?

Accepted Answer

Re-evaluate the risk analysis and implement additional or modified risk control measures.

Question 20

A manufacturer is preparing to release a critical software update for a widely deployed class II medical device that manages patient infusion rates. The update addresses a cybersecurity vulnerability and introduces minor enhancements to the user interface. Considering the principles of ISO 14971:2019 and relevant regulatory expectations for post-market changes, what is the most appropriate risk management action to undertake before deploying this update?

Accepted Answer

Conduct a comprehensive risk assessment of the updated software, evaluating new hazards, changes to existing hazards, and the impact on the overall risk profile of the device, and update the risk management file.

Question 21

A medical device manufacturer has developed a minor firmware update for a widely distributed diagnostic imaging system. This update addresses a non-critical user interface enhancement and includes some internal code refactoring for improved efficiency. While the update does not alter the device\'s core diagnostic algorithms or its intended use, the manufacturer is considering whether a full, formal risk re-evaluation is necessary according to ISO 14971:2019 principles. What is the most appropriate course of action to ensure continued compliance and patient safety?

Accepted Answer

Conduct a comprehensive risk assessment of the modified software, update the risk management file to document the changes and rationale, and verify the effectiveness of implemented risk control measures.

Question 22

A manufacturer is planning to release a significant software update for their class II diagnostic imaging device. This update aims to improve image processing algorithms and introduce a new user interface. Considering the principles outlined in ISO 14971:2019 and the regulatory expectation to maintain device safety, what is the most critical initial step the manufacturer must undertake before deploying this update to the market?

Accepted Answer

Conduct a comprehensive review and update of the existing risk management file to assess the impact of the software changes on device safety.

Question 23

A medical device manufacturer is developing a novel software component for an implantable cardiac rhythm management system. This component is responsible for dynamically adjusting pacing parameters based on real-time physiological feedback. During the risk analysis phase, a potential hazard was identified: \"incorrect pacing parameter adjustment leading to patient harm.\" A risk control measure was implemented, involving a complex algorithm with multiple validation checks. After initial verification testing, the software passed all defined criteria. However, during subsequent usability testing with simulated patient data, a scenario was uncovered where a specific combination of physiological inputs, not fully anticipated in the initial risk analysis, caused the algorithm to make an inappropriate adjustment, albeit one that did not trigger any of the pre-defined verification failure conditions. What is the most appropriate next step according to ISO 14971:2019 principles for managing this situation?

Accepted Answer

Re-evaluate the risk analysis to incorporate the newly identified scenario and implement additional or revised risk control measures, followed by re-verification and re-validation of the modified controls.

Question 24

A medical device manufacturer is updating its established diagnostic software to incorporate a new remote patient monitoring capability. This enhancement involves significant changes to data handling, network communication protocols, and user interface elements. According to the principles outlined in ISO 14971:2019, what is the most appropriate action regarding the device\'s risk management file following this substantial software modification?

Accepted Answer

Conduct a comprehensive re-evaluation of all identified hazards and risks, update the risk management plan and risk analysis, and document these changes thoroughly within the risk management file.

Question 25

Consider a scenario where a medical device\'s embedded software, responsible for critical patient monitoring, requires an update to address a newly discovered cybersecurity vulnerability. This update modifies the data transmission protocols and introduces enhanced encryption algorithms. According to the principles outlined in ISO 14971:2019 for managing risks associated with software, what is the most crucial step to ensure the continued safety and effectiveness of the device post-update?

Accepted Answer

Conduct a thorough risk assessment of the software update, followed by comprehensive verification and validation activities that confirm the cybersecurity measures are effective and no new safety hazards have been introduced.

Question 26

A medical device manufacturer is developing a new software-only diagnostic tool that analyzes patient physiological data to predict the likelihood of a specific adverse event. This tool is intended for use by trained clinicians in an intensive care unit setting. The development team has completed the initial hazard identification and risk analysis for the core functionality. However, a recent internal audit has highlighted potential gaps in how the risk management process has accounted for the dynamic nature of software updates and the potential for emergent risks arising from complex data interactions within the algorithm. Considering the principles outlined in ISO 14971:2019, what is the most critical step to ensure the ongoing safety and effectiveness of this software medical device, particularly in light of the audit findings?

Accepted Answer

Establish a robust post-market surveillance system specifically designed to monitor the software's performance in real-world clinical use, including mechanisms for collecting user feedback and detecting anomalies or unexpected behaviors.

Question 27

When a critical software patch is developed for a networked diagnostic imaging system to address a newly identified cybersecurity vulnerability, what is the most appropriate risk management action according to ISO 14971:2019 principles for a software professional?

Accepted Answer

Conduct a full re-evaluation of the risk management file, specifically analyzing the impact of the patch on existing hazards and control measures, and verifying the effectiveness of any new or modified controls.

Question 28

A medical device manufacturer is preparing to release a significant firmware update for their diagnostic imaging software. This update includes enhancements to image processing algorithms and a new user interface. According to ISO 14971:2019 principles for medical device risk management, what is the most critical action to undertake regarding the existing risk management file before deploying this update?

Accepted Answer

Conduct a comprehensive re-evaluation of all identified hazards and associated risks, considering the impact of the firmware changes on the entire software system and its intended use.

Question 29

A medical device manufacturer is developing a novel diagnostic system that relies on a critical software module developed by an external vendor. The vendor has provided documentation of their risk management process for this module, including identified hazards, risk assessments, and implemented controls. How should the manufacturer best document the integration of this third-party software within their overall risk management file, in accordance with ISO 14971:2019, to ensure comprehensive risk control and traceability?

Accepted Answer

A comprehensive record detailing the review of the vendor's risk management documentation, an independent risk analysis of the integrated system, and a clear articulation of how the third-party module's residual risks are managed within the final medical device.

Question 30

Following the successful market release of a novel AI-driven diagnostic software for a critical care setting, what is the most crucial ongoing risk management activity to ensure continued patient safety and regulatory compliance, considering the dynamic nature of AI algorithms and potential for emergent system behaviors?

Accepted Answer

Systematically collecting and analyzing post-market data, including user feedback, performance metrics, and reported adverse events, to identify and mitigate any newly discovered or evolving risks.

ISO 14971:2019 - Medical Device Risk Management for Software Professional Free Practice Test — 30 Questions

A lot more is already mapped out

About the ISO 14971:2019 - Medical Device Risk Management for Software Professional Certification